← Back to Clinical Trials
Recruiting NCT07120516

NCT07120516 Co-creating School Community Intervention Program on Physical Activity to Increase Health Equity in Children and Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07120516
Status Recruiting
Phase
Sponsor Sandra Andrusaityte
Condition Obese Adolescents
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2025-06-01
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 16 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational and interventional study is to understand whether environmental and behavioral interventions can improve physical activity and health outcomes in children aged 12-16 years attending VDU Atžalynas Progymnasium, Lithuania. The main questions it aims to answer are: 1. Does higher physical activity and improved lifestyle reduce health disparities among children living in disadvantaged social and economic conditions? 2. What is the relationship between environmental pollution, physical activity, and children's health indicators? Researchers will compare data from the cross-sectional group (baseline measurements only) and the intervention group (7-day activity tracking and follow-up after 3 months) to see if targeted environmental interventions improve children's physical activity, sleep quality, and health outcomes. Participants will: * Fill in questionnaires about health behaviors, well-being, and living environment (children and parents). * Undergo physical measurements (blood pressure, height, weight, body composition). * Wear a smart wristband for 7 days to monitor activity, sleep, and heart rate (only for selected participants). * Attend a follow-up visit after 3 months (intervention group only).

Eligibility Criteria

Inclusion Criteria: * Children aged 12-16 years * Attending VDU Atžalynas Progymnasium (Kaunas, Lithuania) * Written informed consent from parents/legal guardians and assent from the child * Willingness to participate in questionnaires, physical measurements, and (if selected) wearable device monitoring Exclusion Criteria: * Younger than 12 or older than 16 years * No signed informed consent from parents/legal guardians or refusal by the child * Medical or psychological conditions that may interfere with participation (e.g., severe cardiovascular disease, mobility impairments, skin allergies preventing wearable use)

Contact & Investigator

Central Contact

Sandra Andrusaityte, PHD

✉ sandra.andrusaityte@vdu.lt

📞 +37068437989

Frequently Asked Questions

Who can join the NCT07120516 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 16 Years, studying Obese Adolescents. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07120516 currently recruiting?

Yes, NCT07120516 is actively recruiting participants. Contact the research team at sandra.andrusaityte@vdu.lt for enrollment information.

Where is the NCT07120516 trial being conducted?

This trial is being conducted at Kaunas, Lithuania.

Who is sponsoring the NCT07120516 clinical trial?

NCT07120516 is sponsored by Sandra Andrusaityte. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology